George Margaritopoulos (London, United Kingdom), Elisabetta Renzoni (London, United Kingdom)
Efficacy of functionalized-imatinib loaded gold nanoparticles on lung fibroblastoid cells from systemic sclerosis patients
Federica Meloni (Pavia, Italy), Emanuela Cova, Simona Inghilleri, Davide Piloni, Veronica Codullo, Laura Pandolfi, Miriam Colombo, Monica Morosini, Valentina Barzon, Sara Magni, Davide Prosperi, Carlomaurizio Montecucco, Federica Meloni
|  |
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Boyang Zheng (Montreal, Canada), Boyang Zheng, Julie Morisset, Sandra Chartrand, Bruno Pierre Dubé
|  |
Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Ourania Koltsida (Athens, Greece), Ourania Koltsida, Evgenia Synolaki, Athanasios Stavropoulos, Pasxalis Sideras, Nikolaos Koulouris, Dimitrios Boumpas, Grigorios Stratakos
| |
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Janne Møller (Skanderborg, Denmark), Janne Møller, Alan Altraja, Tone Sjåheim, Line Bille Madsen, Finn Rasmussen, Elisabeth Bendstrup
| |
Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD)
Francesco Bonella (Dusseldorf, Germany), Francesco Bonella, Yan Lyu, Dirk Theegarten, Eda Boerner, Thomas E. Wessendorf, Ohshimo Shinichiro, Josune Guzman, Ulrich Costabel, Michael Kreuter
| |
Efficacy of switching from cyclosporine A to tacrolimus in patients with refractory CTD-ILD
Yosuke Goto (Seto city, Aichi, Japan), Yosuke Goto, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama, Yasuhiko Yamano
| |
Pulmonary involvement in children with rheumatic diseases
E.Nural Kiper (Ankara, Turkey), Nagehan Emiralioglu, Ezgi Deniz Batu, Emine Sonmez, Gokcen Dilsa Tugcu, Serap Arici, Ebru Yalcin, Deniz Dogru, Ugur Ozcelik, Yelda Bilginer, Mithat Haliloglu, Seza Ozen, Nural Kiper
| |
Survival in CVD-ILD at Ege University Hospital
Nesrin Mogulkoç Bishop (Izmir, Turkey), Nesrin Mogulkoc, Imren Nesil, Aysu Sinem Koc, Zehra Erdemir, Selen Bayraktaroglu, Yasemin Kabasakal, Canan Gunduz, Pervin Korkmaz Ekren, Feza Bacakoglu
| |
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Keita Sakamoto (Tokyo, Japan), Keita Sakamoto, Shinyu Izumi, Masao Hashimoto, Konomi Kobayashi, Ayako Shiozawa, Eriko Suzuki, Shota Yamamoto, Tomoyuki Suzuki, Satoru Ishi, Eriko Morino, Manabu Suzuki, Jin Takasaki, Go Naka, Hiroyuki Yamashita, Motoyasu Iikura, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
| |
Constrictive (obliterative) bronchiolitis as presenting manifestation of connective tissue disease
Antonella Arcadu (Sassari, Italy), Antonella Arcadu, Jay Ryu
| |
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Nevena Djukic (Novi Sad, Republic of Serbia), Nevena Djukic, Zora Pavlovic-Popovic, Bojan Zaric, Marija Vukoja, Milana Panjkovic, Dragan Dragisic
| |
Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Martina Kolbeková (Prague, Czech Republic), Martina Kolbeková, Martina Šterclová, Magdalena Smetáková, Peter Paluch, Jan Anton, Jelena Skibová, Martina Vašáková
| |
Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
Hanna Nurmi (Kuopio, Finland), Hanna Nurmi, Minna Purokivi, Miia Kärkkäinen, Hannu-Pekka Kettunen, Tuomas Selander, Riitta Kaarteenaho
| |
Rituximab in severe, progressive interstitial lung disease
Maria Kokosi (London, United Kingdom), Maria Kokosi, Gregory J. Keir, Tamera J. Corte, Lauren Troy, Peter Saunders, Felix Chua, Toby M. Maher, Elisabetta A. Renzoni, Athol U. Wells
| |
Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
Yutaka Tsuchiya (Tokyo, Japan), Yutaka Tsuchiya, David Lynch, Takeshi Johkoh, Thomas Colby, Junya Fukuoka, Ryoko Egashira, Hiromitsu Sumikawa, Takenori Okada, Jeffrey Swigris, Joshua Solomon
| |
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Riccardo Messina (Palermo, PA, Italy), Riccardo Messina, Alida Benfante, Daniela Castiglia, Claudia I. Gruttad’Auria, Nicola Scichilone
| |
Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Peter George (London, United Kingdom), Peter George, Tristan Huie, Jeff Swigris, Kern Buckner, Kevin Brown, Brett Fenster
| |